Fluorescence-guided surgery with live molecular navigation--a new cutting edge
- PMID: 23924645
- PMCID: PMC4427343
- DOI: 10.1038/nrc3566
Fluorescence-guided surgery with live molecular navigation--a new cutting edge
Abstract
A glowing new era in cancer surgery may be dawning. Using fluorescently labelled markers, surgical molecular navigation means that tumours and nerves can be displayed in real time intra-operatively in contrasting pseudocolours, which allows more complete tumour resection while preserving important structures. These advances can potentially cause a paradigm shift in cancer surgery, improving patient outcome and decreasing overall health-care costs.
Conflict of interest statement
The authors declare no competing financial interests.
Figures


Comment in
-
Fluorescence-guided surgery of malignant gliomas based on 5-aminolevulinic acid: paradigm shifts but not a panacea.Nat Rev Cancer. 2014 Feb;14(2):146. doi: 10.1038/nrc3566-c1. Nat Rev Cancer. 2014. PMID: 24457418 No abstract available.
References
-
- National Cancer Institute. Previous version: SEER cancer statistics review, 1975–2005. 2008 [online], http://seer.cancer.gov/csr/1975_2005.
-
- Singletary S. Surgical margins in patients with early-stage breast cancer treated with breast conservation therapy. Am J Surg. 2002;184:383–393. - PubMed
-
- Meric F, et al. Positive surgical margins and ipsilateral breast tumor recurrence predict disease-specific survival after breast-conserving therapy. Cancer. 2003;97:926–933. - PubMed
-
- Snijder R, de la Riviere A, Elbers H, van den Bosch J. Survival in resected stage I lung cancer with residual tumor at the bronchial resection margin. Ann Thorac Surg. 1998;65:212–216. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources